Canaccord analyst Kyle Mikson lowered the firm’s price target on Illumina (ILMN) to $87 from $92 and keeps a Hold rating on the shares. The firm said they remain on the sidelines after they updated its 2025 guidance for multiple complicated headwinds that add further uncertainty to the company’s return to growth mode.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target lowered to $100 from $136 at Morgan Stanley
- Illumina’s Hold Rating Amidst Strong Instrument Sales and Challenges in Chinese Market
- Illumina’s Earnings Call: Mixed Outlook Amid Challenges
- Illumina price target lowered to $135 from $160 at Stifel
- Illumina price target raised to $89 from $86 at TD Cowen